Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2116 to 2130 of 7682 results

  1. Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  2. Radiofrequency denervation for OA shoulder pain

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  3. Atezolizumab with cabozantinib for treating metastatic non-small-cell lung cancer after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812

      Status ...

    Health technology evaluations
    Topic selection

  4. Transcatheter Tricuspid Valve Replacement

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  5. Tebentafusp for treating advanced (unresectable or metastatic) uveal melanoma [ID1441]

    In development [GID-TA10428] Expected publication date: TBC

    Technology appraisal guidance
    In development

  6. Palbociclib with trastuzumab and endocrine therapy for maintenance treatment of hormone-receptor positive, HER2-positive metastatic breast cancer [ID6251]

    Awaiting development [GID-TA11273] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  7. Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]

    In development [GID-TA11484] Expected publication date: 26 February 2025

    Technology appraisal guidance
    In development

  8. Pembrolizumab with chemotherapy for treating hormone receptor-positive HER2-negative locally recurrent inoperable or metastatic breast cancer [ID6285]

    Awaiting development [GID-TA11342] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Nivolumab with ipilimumab for untreated advanced hepatocellular carcinoma [ID6239]

    Awaiting development [GID-TA11116] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  10. Pegargiminase with pemetrexed and cisplatin for untreated advanced malignant pleural mesothelioma [ID1575]

    Awaiting development [GID-TA10486] Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Vonicog alfa for preventing haemorrhage in people with von Willebrand disease when desmopressin is ineffective or not suitable ID 6272

      Status ...

    Health technology evaluations
    Topic selection

  12. Bismuth subcitrate potassium–metronidazole–tetracycline hydrochloride with omeprazole for treating Helicobacter pylori and preventing peptic ulcer relapse TS ID 11900

      Status ...

    Health technology evaluations
    Topic selection

  13. Pegcetacoplan for treating geographic atrophy [ID4041]

    In development [GID-TA11351] Expected publication date: TBC

    Technology appraisal guidance
    In development

  14. Rapid tests for group A streptococcal infections in people with a sore throat (DG38)

    Evidence-based recommendations on rapid tests for group A streptococcal infections in people aged 5 and over with a sore throat

    Diagnostics guidance
    Published
    13 November 2019
    View recommendations

    Sections for DG38

  15. SepsiTest assay for rapidly identifying bloodstream bacteria and fungi (DG20)

    Evidence-based recommendations on the SepsiTest assay for rapidly identifying bloodstream bacteria and fungi

    Diagnostics guidance
    Last updated
    19 February 2020

    Sections for DG20